Chen Yan, Mei Yu-Qi, Hou Lin, Li Ke-Jian
Research Institute of Marine Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Qingdao, China.
Qingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, China.
Front Pharmacol. 2025 Sep 1;16:1652860. doi: 10.3389/fphar.2025.1652860. eCollection 2025.
Drug-induced liver injury (DILI) is a major cause of drug development failure and post-marketing restrictions. To date, over 1,000 drugs have been reported to cause liver damage, such as acetaminophen, isoniazid, methotrexate, triptolide and so on. However, there are currently no effective therapies for DILI. Plant-derived natural products including flavonoids, phenylpropanoids, terpenoids, and glycosides have been used for the treatment of DILI due to their low toxicity and strong bioactivity. These anti-DILI compounds involve multiple mechanisms, such as reducing oxidative stress and inflammation, restoring mitochondrial function, and suppressing apoptosis. This review primarily summarizes the recent advances over the past 5 years in the therapeutic potential of natural products against a range of commonly used hepatotoxic drugs rather than focusing on a specific hepatotoxic agent. The insights will provide a cue for further research and promote the development of novel and effective drugs for treating DILI.
药物性肝损伤(DILI)是药物研发失败和上市后受限的主要原因。迄今为止,已有超过1000种药物被报道可导致肝损伤,如对乙酰氨基酚、异烟肼、甲氨蝶呤、雷公藤内酯醇等。然而,目前尚无针对DILI的有效治疗方法。包括黄酮类、苯丙素类、萜类和糖苷类在内的植物源天然产物因其低毒性和强生物活性而被用于治疗DILI。这些抗DILI化合物涉及多种机制,如减轻氧化应激和炎症、恢复线粒体功能以及抑制细胞凋亡。本综述主要总结了过去5年天然产物针对一系列常用肝毒性药物的治疗潜力的最新进展,而非聚焦于某一种特定的肝毒性药物。这些见解将为进一步研究提供线索,并促进治疗DILI的新型有效药物的开发。